Oklahoma City, OKLAHOMA3 Active Studies

Atopic Dermatitis Clinical Trials in Oklahoma City, OKLAHOMA

Find 3 actively recruiting atopic dermatitis clinical trials in Oklahoma City, OKLAHOMA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
433
Enrolling

Recruiting Atopic Dermatitis Studies in Oklahoma City

About Atopic Dermatitis Clinical Trials in Oklahoma City

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 3 atopic dermatitis clinical trials recruiting participants in Oklahoma City, OKLAHOMA. These studies are seeking a combined 433 participants. Research is being sponsored by Northwell Health, BioInvent International AB, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Oklahoma City — FAQ

Are there atopic dermatitis clinical trials in Oklahoma City?

Yes, there are 3 atopic dermatitis clinical trials currently recruiting in Oklahoma City, OKLAHOMA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oklahoma City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.

Are clinical trials in Oklahoma City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 3 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated March 2, 2026 from ClinicalTrials.gov